DNDi is hosting an meeting with mycetoma experts to discuss DNDi’s Mycetoma Strategic Plan (2023-2028).
Agenda
Thursday, 1 June 2023
| 8:30 | Welcome Fabiana Alves, NTD Leishmaniasis-Mycetoma Cluster Director, DNDi |
| 8:40 | Introduction to DNDi Mycetoma Strategic Plan (2023-2028) Borna Nyaoke, Head of Mycetoma Disease, DNDi |
Session 1: Global Overview of Mycetoma
9:00-10:30
Chair: Borna Nyaoke, Head of Mycetoma Disease, DNDi
| Eumycetoma: What are the data and management gaps? David Denning, University of Manchester |
| Mycetoma Survey and Integration in the framework of NTDs with cutaneous manifestation Augustin Ebeja, World Health Organization |
| Progress in understanding of Eumycetoma in the past 20 years; the laboratory perspective Wendy van de Sande, Erasmus MC |
Session 2: Country Experiences
11:00-15:00
Chair: Augustin Ebeja, World Health Organization
| Sudan Ahmed Fahal, Mycetoma Research Center, Khartoum |
| Ethiopia Wendemagegn Enbiale, Bahir Dar University |
| India Dilip Kachhawa, Dr. SN Medical College, Jodhpur |
| Senegal Doudou Sow, University Cheikh Anta Diop |
| Nigeria Rita Oladele, University of Lagos |
| Mexico Guadalupe Estrada-Chavez, Community Dermatology |
| Tanzania Daudi Mavura, Kilimanjaro Christian Medical Center |
| Kenya Kika Colom, Universitas Miguel Hernández |
| Uganda Felix Bongomin/ Richard Kwizera, Gulu University |
Technical discussions- Sessions 1 & 2
15:00-16:30
Friday, 2 June 2023
Session 3: Fosravuconazole Phase II clinical trial
8:30-9:40
Chair: Fabiana Alves, NTD Leishmaniasis-Mycetoma Cluster Director, DNDi
| Main trial results Ahmed Fahal, Mycetoma Research Center, Khartoum |
| Microbiology results Wendy van de Sande, Erasmus MC |
| Pharmacokinetic results Thomas Dorlo, Uppsala University, Sweden |
Technical discussions- Session 3
9:40- 11:00
Session 4: Mycetoma landscape and future treatments
11:30-12:00
Chair: Kyoko Nakano, Eisai Ltd., Japan
| 20 years’ experience in Mycetoma in West Africa Michel Develoux, Sorbonne University, France |
| Mycetoma in India: options for a joint approach (Diagnosis and Management) with other fungal infections? Shivaprakash M Rudramurthy, Postgraduate Institute of Medical Education and Research, Chandigarh, India |
| MycetOS Wendy van de Sande, Erasmus MC |
| Contribution to the treatment of NTDs – development of fosravuconazole Katsura Hata, Eisai Ltd., Japan |
| Issues in Eumycetoma treatment; suggestions on the way forward Eduard Zijlstra, Consultant Expert PKDL/Mycetoma, DNDi |
Technical discussions- Session 4
15:00- 15:40
Closing remarks
16:20-16:30
Monique Wasunna, Eastern Africa Director, DNDi
